Interestingly, we demonstrated that MDM2 mRNA transcript levels were highly elevated in CD34+ stem/progenitor cells from 23 CML samples as compared to 11 NBM samples by qRT-PCR analysis (p = 0.0396, Figure 4A). This evidence concerns the gene CD34 and chronic myelogenous leukemia, BCR-ABL1 positive.